Newswise — Early detection improves the prospects for treatment for most diseases, and Alzheimer disease is no exception. In the past decade, the concept of mild cognitive impairment—a diminution of mental function, usually including memory domains, that falls short of frank dementia but exceeds the normal changes of aging—has provided a way to identify people at a higher risk of developing AD and opened a window of opportunity for intervention. The MCI construct has enabled imaging and other studies of earlier and earlier stages of AD. In setting the agenda for the 7th Annual Mild Cognitive Impairment (MCI) Symposium, host Ranjan Duara, Director of the Wien Center for Alzheimer's Disease and Memory Disorders at Mount Sinai Medical Center in Miami Beach, Florida, aimed to offer participants the latest in a broad range of MCI research, in AD as well as in other dementias. Twenty-four speakers in four sessions covered topics ranging from the imaging and neuropathology of what are now recognized as many subtypes of MCI, to the prodromal manifestations of non-AD dementias, to the important question of the role of vascular factors in dementia and its prevention.
The Alzheimer Research Forum (www.alzforum.org) presents writer Pat McCaffrey's report on the meeting together with 19 powerpoint lectures. Visit the following link to view the report and powerpoints:http://www.alzforum.org/res/for/vir/miami/default.asp
The Alzheimer Research Forum (www.alzforum.org), founded in 1996, is the web's most dynamic scientific community dedicated to understanding Alzheimer disease and related disorders. Access to the web site is free to all. The Forum's editorial priorities are as diverse as the needs of the research community. The web site reports on the latest scientific findings, from basic research to clinical trials; creates and maintains public databases of essential research data and reagents; and produces discussion forums to promote debate, speed the dissemination of new ideas, and break down barriers across the numerous disciplines that can contribute to the global effort to cure Alzheimer's disease.
The ARF team of professional science writers and editors, information technology experts, web developers and producers all work closely with its distinguished and diverse Advisory Board to ensure a high quality of information and services. The Alzheimer Research Forum is an independent nonprofit organization supported by grants and individual donations. The web site does not endorse any specific product or scientific approach.
RSS